Try it
OBG · Hypertensive disorders: mechanism of aspirin prophylaxis
Sample itemLow-dose aspirin reduces the risk of pre-eclampsia in high-risk women. Which mechanism explains this?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. Selective inhibition of platelet thromboxane A2 synthesis, restoring the thromboxane-prostacyclin balance
In pre-eclampsia thromboxane A2, a vasoconstrictor and platelet aggregator, dominates over prostacyclin. Low-dose aspirin irreversibly inhibits platelet cyclo-oxygenase and spares endothelial prostacyclin, so the balance shifts towards vasodilatation. It is started early in the second trimester or before, in high-risk women.
Option by option
A. Inhibition of endothelial prostacyclin synthesis
Aspirin does not inhibit endothelial prostacyclin at low dose; blocking it would worsen the imbalance.
B. Direct reduction of circulating sFlt-1
Aspirin has no direct action on circulating sFlt-1.
C. Selective inhibition of platelet thromboxane A2 synthesis, restoring the thromboxane-prostacyclin balance (correct)
Correct. Low doses inhibit platelet thromboxane while sparing prostacyclin.
D. Blockade of angiotensin II receptors in the uterine vessels
Angiotensin receptor blockers act on the renin-angiotensin system and are contraindicated in pregnancy.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More OBG questions
- Antenatal careA woman's last menstrual period began on 10 January 2026. Using Naegele's rule, what is…
- Obstetric drugsCarboprost (15-methyl PGF2α) is contraindicated in which condition?
- Hypertensive disorders of pregnancyA primigravida at 34 weeks has a blood pressure of 150/100 mmHg on two occasions and 2+…
- Obstetric immunologyAn Rh-negative mother delivers an Rh-positive baby. When should anti-D immunoglobulin be…